Report Company Directory
- U.S. Medical Supplies & Devices: Recap & Preview – Upside in Devices from JNJ, ABT and ISRG; New dV5 is a ‘Win’; Wk 2 Earnings Up Next (BSX, DXCM, EW) and More GMED and Spine Mkt Checks at ISASS by Barclays
- US Investment Grade: Top Swaps in Yankees: Banks, Utilities, Comms, and Energy by Barclays
- U.S. Medical Supplies & Devices: Why We See the ‘SYK vs. ISRG’ Buzz Around da Vinci 5 as a False Match-Up – Early Take-Aways from SAGES Day 1 by Barclays
- Johnson & Johnson: First Look: Upside in Cardio, Pharma and Ortho Offset by Vision and Surgery to Deliver In-Line Sales and +6c Cons EPS; Mgmt Raises Bottom End of Range for Sales and Narrows EPS by Barclays
- Smith & Nephew plc: Read-across from JNJ 1Q24 results by Barclays
- U.S. Medical Supplies & Devices: UPDATE: Q1 MedTech Group Performance Positioned to Beat Street Expectations by Barclays
- U.S. Medical Supplies & Devices: Recap & Preview – IMAST Pos for GMED; We Expect JNJ, ABT and ISRG Earnings to Feature Healthy Volumes; dV 5 Expected to Capture Spotlight at SAGES by Barclays
- US Medical Supplies and Devices "1Q24 Preview: Results Likely More Subdued..." by UBS AG
- U.S. Medical Supplies & Devices: Recap & Preview – JNJ Makes SWAV Deal ‘Official’, SMART Trial Sparks Excitement and Debate, BAX Next-Gen Pump Approved by Barclays
- Global Medical Technology & Services: Global Orthopaedics Survey 4.0: The strength continues by Barclays